HCRTR2 and Cataplexy: Successful models also demonstrate in vivo indicators consistent with human narcolepsy—such as altered vigilance stability, REM–NREM dynamics, and cataplexy-like episodes—and exhibit pharmacological responsiveness comparable to that observed clinically with agents like modafinil, sodium oxybate, or OX2R agonists.